Bioavailability of ABT-333 Within the Gastrointestinal Tract in Healthy Subjects

Study Identifier
M14-108
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Healthy Volunteer
  • Study Drug
  • ABT-333
  • Phase
    Phase 1
    Sex
    Female & Male
    Age
    18 - 65 Years

    Protocol Summary

    This open label, Phase 1 study is to investigate the relative bioavailability of ABT-333 when delivered within different sites of the gastrointestinal tract in 12 healthy subjects.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 118435
    Nottingham, United Kingdom, NG11 6JS
    Status
    Not applicable